ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BMY Bristol Myers Squibb Co

47.60
-1.26 (-2.58%)
Pre Market
Last Updated: 09:09:41
Delayed by 15 minutes

Period:

Draw Mode:

Volume 216,236
Bid Price
Ask Price
News (1)
Day High

Low
47.58

52 Week Range

High
70.935

Day Low
Company Name Stock Ticker Symbol Market Type
Bristol Myers Squibb Co BMY NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.26 -2.58% 47.60 09:09:41
Open Price Low Price High Price Close Price Prev Close
48.86
Trades Volume Avg Volume 52 Week Range
2,552 216,236 - 47.58 - 70.935
Last Trade Time Type Quantity Stock Price Currency
09:09:42 1 $ 47.53 USD

Bristol Myers Squibb (BMY) Options Flow Summary

Overall Flow

Bearish

Net Premium

-23M

Calls / Puts

21.62%

Buys / Sells

85.42%

OTM / ITM

7.14%

Sweeps Ratio

0.04%

Bristol Myers Squibb Co Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
98.8B 2.02B - 45.01B 8.03B 3.97 12.31
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Bristol Myers Squibb News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BMY Message Board. Create One! See More Posts on BMY Message Board See More Message Board Posts

Historical BMY Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week47.9449.5647.61548.8210,869,829-0.34-0.71%
1 Month53.3954.47547.61550.2011,069,328-5.79-10.84%
3 Months48.8655.03547.5851.0015,544,520-1.26-2.58%
6 Months56.0256.7747.5850.9115,483,656-8.42-15.03%
1 Year70.6870.93547.5855.2612,734,367-23.08-32.65%
3 Years66.0081.43547.5863.8611,513,311-18.40-27.88%
5 Years45.0581.43541.1961.0012,268,6202.555.66%

Bristol Myers Squibb Description

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

Your Recent History

Delayed Upgrade Clock